Novel attempts launched toward universal Sarbecovirus vaccine
Cell Res
.
2021 Dec;31(12):1226-1227.
doi: 10.1038/s41422-021-00556-z.
Authors
Haoyang Li
1
,
Erica Ollmann Saphire
2
3
Affiliations
1
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA, USA.
2
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA, USA. erica@lji.org.
3
Department of Medicine, University of California San Diego, La Jolla, CA, USA. erica@lji.org.
PMID:
34433899
PMCID:
PMC8385477
DOI:
10.1038/s41422-021-00556-z
No abstract available
Publication types
Comment
MeSH terms
Spike Glycoprotein, Coronavirus*
Vaccines*
Substances
Spike Glycoprotein, Coronavirus
Vaccines
Grants and funding
U19 AI142790/AI/NIAID NIH HHS/United States
U19 AI142790-S1/U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
OPP1210938/Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation)